Current Issue

Advanced Therapy Medicinal Products Technology Transfer Challenges – Part 3

Robert Dream, Managing Director, HDR Company LLC

Advances and Challenges in Vaccine Development and Manufacture

Tony D’Amore, Ph.D. MBA, Board Member, Scientific Advisor and Independent Consultant for...

Endotoxin Control Strategies for Parenteral Drug Product Manufacturing

Robert Simler, Associate Vice President, Process Development, Amgen (previously Associate ...

Current Trends in Control and Monitoring of Subvisible Particulate Matter in Biotherapeuti...

Satish (Kumar) Singh, Vice President, Drug Product Development, Astria Therapeutics, Inc. ...

Lifetime Study for JSR Amsphere A3 – Protein A Resin

JSR Life Sciences


Featured Articles

Navigating Technology Transfer

Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma

Expanding Adoption of Single-Use Systems Drives Need for Wider Range of Sterile Connector Technologies

James Barry, Director of Marketing, Americas, Pall Biotech

Continuous Bioprocessing: PAT Strategies in Support of Process Monitoring and Control to Enable Rapid Product Release

By: Jeffrey DoyleManager, PAT Projects in the Process Analytical Sciences Group
Paul JeffersManager, PAT Projects in Process Analytical Sciences Group, Global Technology Services
Seamus O’NeillAnalytical Chemist
Pfizer

View All Featured Articles

Headline News

Johnson & Johnson survey finds AI use rising in community oncology but implementation barriers remain


Eli Lilly finalizes purchase of AtaiBeckley, expanding its pipeline for treatment-resistant depression and other mental health conditions


Gilead unveils new Foster City facility dedicated to oncology, inflammation, and data science research


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Regulatory Strategies and Case Studies for Rapid Sterility Testing of Gene and Cell Therapy Products

Presented by Dr. Michael J. Miller, President of Microbiology Consultants, LLC and Lori Daane Pharma Microbiology Scientific Director at bioMérieux
23rd May 2019


Fully Utilizing Closed Systems in Modern BioPharma Facilities

Presented by Lars Hovmand-Lyster, Senior Engineering Specialist in Novo Nordisk Global Project Office (GPO) Engineering Management Department and Ross W. Acucena, Applications Director, Entegris LifeScience
03rd September 2020


Commercial Cell Therapy Experience Using Mycoplasma NAT For Product Release: Five-Year Review

Presented by John Duguid, Executive Director, Research & Development at Vericel Corporation and Lori Daane, Pharma Microbiology Sr. Scientific Director at bioMérieux and Mike Brewer, Director, Global Principal Consultant, Regulatory, BioProduction at Thermo Fisher Scientific
01st November 2022


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia